PROCYSTEINE
Dead / Cancelled — Cancelled — Section 8 (as of 09 Aug 2003)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74123084
- Registration number
- 1730224
- Mark type
- Word mark
- Filed
- 13 Dec 1990
- Published for opposition
- 03 Mar 1992
- Registered
- 03 Nov 1992
- Attorney of record
- Robert M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical compounds for stimulating intracellular synthesis of peptides and proteins for the treatment of a wide variety of diseases
Owner
- TRANSCEND THERAPEUTICS, INC., CAMBRIDGE, MA, US
- CLINTEC NUTRITION COMPANY, Deerfield, IL, US
- CLINTEC NUTRITION COMPANY, Deerfield, IL, US
- CLINTEC NUTRITION COMPANY, Deerfield, IL, US
Prosecution history
- 09 Aug 2003 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 15 Mar 1999 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Oct 1998 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 03 Nov 1992 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 1992 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Aug 1992 — ASSIGNED TO EXAMINER
- 24 Aug 1992 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Aug 1992 — USE AMENDMENT FILED
- 26 May 1992 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 03 Mar 1992 — PUBLISHED FOR OPPOSITION
- 31 Jan 1992 — NOTICE OF PUBLICATION
- 28 Aug 1991 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 1991 — EXAMINER'S AMENDMENT MAILED
- 20 Mar 1991 — ASSIGNED TO EXAMINER